Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.69% |
| 2 | Financials | 6.83% |
| 3 | Healthcare | 6.42% |
| 4 | Industrials | 4.98% |
| 5 | Consumer Discretionary | 4.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
CALL
Enbridge
ENB
$110B
| $47.4M | 0.03% |
+940,000
| New | +$37.1M |
|
|
GTM
652
ZoomInfo Technologies
GTM
$1.16B
| $47.4M | 0.03% |
775,018
+547,950
| +241% | +$32.8M |
|
653
Northern Trust
NTRS
$33.6B
| $47.1M | 0.03% |
437,271
+74,767
| +21% | +$8.49M |
|
654
Neurocrine Biosciences
NBIX
$15.5B
| $47.1M | 0.03% |
491,244
+369,733
| +304% | +$34.9M |
|
655
Snowflake
SNOW
$115B
| $47.1M | 0.03% |
155,747
+95,086
| +157% | +$27M |
|
|
XLRN
656
DELISTED
Acceleron Pharma
XLRN
| $47.1M | 0.03% |
273,520
+261,193
| +2,119% | +$34.2M |
|
|
IPOF
657
DELISTED
Social Capital Hedosophia Holdings Corp. VI
IPOF
| $47M | 0.03% |
4,632,932
+353,446
| +8% | +$3.55M |
|
658
Gartner
IT
$12.4B
| $47M | 0.03% |
154,739
-67,861
| -30% | -$19.7M |
|
659
Exelon
EXC
$45.1B
| $47M | 0.03% |
1,362,883
+622,854
| +84% | +$21.3M |
|
660
CALL
Las Vegas Sands
LVS
$30.5B
| $46.9M | 0.03% |
1,282,200
+752,200
| +142% | +$32.3M |
|
661
SS&C Technologies
SSNC
$19.5B
| $46.9M | 0.03% |
675,589
-247,646
| -27% | -$18.4M |
|
|
PACW
662
DELISTED
PacWest Bancorp
PACW
| $46.8M | 0.03% |
1,033,677
+596,219
| +136% | +$24.7M |
|
663
Performance Food Group
PFGC
$16.5B
| $46.8M | 0.03% |
1,008,144
-307,671
| -23% | -$14.2M |
|
664
Align Technology
ALGN
$11.5B
| $46.8M | 0.03% |
70,275
-171,226
| -71% | -$116M |
|
665
CALL
Thermo Fisher Scientific
TMO
$233B
| $46.7M | 0.03% |
81,700
+60,200
| +280% | +$33M |
|
|
MGP
666
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $46.7M | 0.03% |
1,218,468
-492,816
| -29% | -$19.3M |
|
667
Gaming and Leisure Properties
GLPI
$12.7B
| $46.6M | 0.03% |
1,006,788
+224,441
| +29% | +$10.7M |
|
668
Datadog
DDOG
$84.6B
| $46.6M | 0.03% |
329,881
+74,148
| +29% | +$9.36M |
|
669
Churchill Downs
CHDN
$6.53B
| $46.6M | 0.03% |
387,972
-448,712
| -54% | -$45.6M |
|
|
VMW
670
PUT
DELISTED
VMware, Inc
VMW
| $46.3M | 0.03% |
311,600
-49,800
| -14% | -$7.55M |
|
671
Bio-Techne
TECH
$11.3B
| $46.3M | 0.03% |
382,360
+346,188
| +957% | +$42.1M |
|
672
Sociedad Química y Minera de Chile
SQM
$23.4B
| $46.3M | 0.03% |
862,036
+419,278
| +95% | +$21.4M |
|
673
CALL
Sun Life Financial
SLF
$44B
| $46.3M | 0.03% |
+710,000
| New | +$36.5M |
|
674
Upstart Holdings
UPST
$2.95B
| $46M | 0.03% |
145,524
+116,996
| +410% | +$23.1M |
|
675
Air Products & Chemicals
APD
$67.9B
| $46M | 0.03% |
179,581
+38,193
| +27% | +$10.6M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander deployed $8.65B of net new capital in Q3 2021, opening 1,245 new positions and adding to 2,719 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.2% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.